Please use this identifier to cite or link to this item:
|Title:||Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice|
Britton, Robert G.
Steward, William P.
Gescher, Andreas J.
|Citation:||Science Translational Medicine, 2015, 7 (298), pp. 298ra117|
|Abstract:||Resveratrol is widely promoted as a potential cancer chemopreventive agent, but a lack of information on the optimal dose prohibits rationally designed trials to assess efficacy. To challenge the assumption that "more is better," we compared the pharmacokinetics and activity of a dietary dose with an intake 200 times higher. The dose-response relationship for concentrations generated and the metabolite profile of [(14)C]-resveratrol in colorectal tissue of cancer patients helped us to define clinically achievable levels. In Apc(Min) mice (a model of colorectal carcinogenesis) that received a high-fat diet, the low resveratrol dose suppressed intestinal adenoma development more potently than did the higher dose. Efficacy correlated with activation of adenosine monophosphate-activated protein kinase (AMPK) and increased expression of the senescence marker p21. Nonlinear dose responses were observed for AMPK and mechanistic target of rapamycin (mTOR) signaling in mouse adenoma cells, culminating in autophagy and senescence. In human colorectal tissues exposed to low dietary concentrations of resveratrol ex vivo, we measured enhanced AMPK phosphorylation and autophagy. The expression of the cytoprotective NAD(P)H dehydrogenase, quinone 1 (NQO1) enzyme was also increased in tissues from cancer patients participating in our [(14)C]-resveratrol trial. These findings warrant a revision of developmental strategies for diet-derived agents designed to achieve cancer chemoprevention.|
|Rights:||Copyright © 2015, American Association for the Advancement of Science. Deposited with reference to the publisher’s archiving policy available on the SHERPA/RoMEO website and on http://www.sciencemag.org/site/feature/contribinfo/prep/license.xhtml|
|Description:||The version of record is available on the Publisher links provided above 12 months after publication.|
|Appears in Collections:||Published Articles, Dept. of Cancer Studies and Molecular Medicine|
Files in This Item:
|Cai et al main text and supplementary info.pdf||Post-review (final submitted)||1.59 MB||Adobe PDF||View/Open|
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.